Klaus Radermacher Joins Conformis Scientific Advisory Board to Advance True Patient Specific Implant Platform
Conformis, Inc. leverages Professor Radermacher’s expertise for the next steps in patient specific technology innovation
Burlington, Mass.— April 18, 2011 — Prof. Klaus Radermacher has joined the Conformis Scientific Advisory Board to participate in the next stage of innovation for Conformis patient specific implants and instrumentation. Prof. Radermacher is Chair of Medical Engineering at the Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
Conformis uses computer modeling and proprietary software to build a 3D image of a patient’s knee from CT images. That image then guides the design and manufacture of an implant that conforms precisely to the articular surfaces of the patient’s joint. This iFit® technology produces individualized, patient-specific implants without the sizing and fit compromises that can lead to poor clinical results.
Prof. Radermacher performed groundbreaking work in the design of individual templates for use in orthopedic surgery nearly twenty years ago. Prof. Radermacher also has made many seminal contributions to image guided surgery, surgical navigation, and medical robotics. He has been an invited lecturer at many national and international meetings including the Computer Assisted Orthopedic Surgery conference for the last two decades. He is an active inventor having contributed to several patents.
“Patient specific instrumentation is changing the way orthopedic surgery and, specifically, knee replacement is practiced today,” said Prof. Radermacher. “Conformis has advanced the technology and become the leader in this field by developing innovative clinical applications that are revolutionizing the repair, replacement and resurfacing of complex articulating joints, such as the knee. Conformis has taken patient specific technology to a new level by not only pioneering new approaches for patient specific jigs, but also by developing truly patient specific implants. Conformis’ combination of patient specific instruments and implants unlocks the full power of this technology. I look forward to participating in the development of future generations of this technology.”
“I am extremely pleased that Professor Radermacher has joined our Scientific Advisory Board,” said Philipp Lang, CEO of Conformis. “Professor Radermacher has a wealth of historical knowledge and expertise spanning the full range of computer assisted orthopedic surgery. We are excited that he will bring his knowledge and expertise to his work with Conformis. He is one of the leading innovators in computer assisted surgical applications in Orthopedics and we are thrilled that he will participate in the development of future applications for our patient specific implant and instrument technology”.
For more information on Conformis visit www.conformis.com .
About Conformis, Inc.
Conformis, Inc. is a privately-held company that develops and commercializes medical devices for osteoarthritis treatment and joint damage. Its proprietary intellectual property includes more than 250 patents and patent applications in the areas of imaging software, image processing, implant design, surgical techniques, instrumentation, and manufacturing, spanning knee, hip, shoulder, spine, and small joints. Conformis knee implants and instrumentation are designed to address all stages of osteoarthritis, the most common reason for knee replacement surgery . All devices have been cleared by the US Food and Drug Administration for marketing in the US. In 2009, Conformis was named a winner of the Medical Design Excellence Awards, the premier recognition for contributions and advances in the design of medical products, for its iUni and iDuo resurfacing implants. Follow Conformis on Twitter at @Conformis and become a fan on Facebook at www.facebook.com/Conformis.
New Implant Technology, A New Twist On Knee Replacement
The Cape Cod Chronicle: ConforMIS, is breaking new ground in the field of knee replacements by offering something never seen before: customized knee implants designed and manufactured for each individual patient, with no two quite alike.
Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR
Data Shows a Low Cumulative Percent Revision of 0.5% for Conformis Patients vs 1.9% for all Total Knee Replacement Patients